Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Bokemeyer

Showing results (111-120 of 333) with videos related to

Pageof 34
Sort By:
Deutsche Medizinische Wochenschrift (1946)|October 1, 2014
[55-year old woman, smoking, with obvious exhaustion, fever and hemopysis]N H Thoennissen, T Clauditz, H Ittrich, et al.
Seminars in Surgical Oncology|December 10, 1999
Late toxicity following curative treatment of testicular cancerC Kollmannsberger, M Kuzcyk, F Mayer, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1994
Preliminary results of a phase I/II trial of paclitaxel in patients with relapsed or cisplatin-refractory testicular cancerC Bokemeyer, H J Schmoll, F Natt, et al.
British Journal of Cancer|May 1, 1994
The anti-tumour activity of ifosfamide on heterotransplanted testicular cancer cell lines remains unaltered by the uroprotector mesnaC Bokemeyer, H J Schmoll, E Ludwig, et al.
European Journal of Cancer (Oxford, England : 1990)|December 1, 1995
Secondary Raynaud's phenomenon and other late vascular complications following chemotherapy for testicular cancerC C Berger, C Bokemeyer, M Schneider, et al.
European Journal of Cancer (Oxford, England : 1990)|May 1, 1997
Comparison of histological results from the resection of residual masses at different sites after chemotherapy for metastatic non-seminomatous germ cell tumoursJ T Hartmann, M Candelaria, M A Kuczyk, et al.
Der Urologe. Ausg. A|September 29, 1999
[New aspects on the identification of genetic alterations and prognostically important biological parameters in renal cell cancer]S Machtens, M Kuczyk, A J Becker, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Preclinical activity of a new platinum analogue, lobaplatin, in cisplatin-sensitive and -resistant human testicular, ovarian, and gastric carcinoma cell linesA Harstrick, C Bokemeyer, M Scharnofkse, et al.
British Journal of Haematology|February 16, 2023
Increased incidence of immune thrombocytopenia (ITP) in 2021 correlating with the ongoing vaccination campaign against COVID-19 in a tertiary center - A monocentric analysisC Schaefers, F-O Paulsen, C Frenzel, et al.
Medizinische Klinik (Munich, Germany : 1983)|November 15, 1996
[Risk of secondary neoplasia after treatment of malignant germ cell tumors of the testis]C Bokemeyer, M A Kuczyk, C H Köhne, et al.
Pageof 34

Showing results (111-120 of 333) with videos related to

Sort By:
Pageof 34
Deutsche Medizinische Wochenschrift (1946)|October 1, 2014
[55-year old woman, smoking, with obvious exhaustion, fever and hemopysis]N H Thoennissen, T Clauditz, H Ittrich, et al.
Seminars in Surgical Oncology|December 10, 1999
Late toxicity following curative treatment of testicular cancerC Kollmannsberger, M Kuzcyk, F Mayer, et al.
Journal of Cancer Research and Clinical Oncology|January 1, 1994
Preliminary results of a phase I/II trial of paclitaxel in patients with relapsed or cisplatin-refractory testicular cancerC Bokemeyer, H J Schmoll, F Natt, et al.
British Journal of Cancer|May 1, 1994
The anti-tumour activity of ifosfamide on heterotransplanted testicular cancer cell lines remains unaltered by the uroprotector mesnaC Bokemeyer, H J Schmoll, E Ludwig, et al.
European Journal of Cancer (Oxford, England : 1990)|December 1, 1995
Secondary Raynaud's phenomenon and other late vascular complications following chemotherapy for testicular cancerC C Berger, C Bokemeyer, M Schneider, et al.
European Journal of Cancer (Oxford, England : 1990)|May 1, 1997
Comparison of histological results from the resection of residual masses at different sites after chemotherapy for metastatic non-seminomatous germ cell tumoursJ T Hartmann, M Candelaria, M A Kuczyk, et al.
Der Urologe. Ausg. A|September 29, 1999
[New aspects on the identification of genetic alterations and prognostically important biological parameters in renal cell cancer]S Machtens, M Kuczyk, A J Becker, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Preclinical activity of a new platinum analogue, lobaplatin, in cisplatin-sensitive and -resistant human testicular, ovarian, and gastric carcinoma cell linesA Harstrick, C Bokemeyer, M Scharnofkse, et al.
British Journal of Haematology|February 16, 2023
Increased incidence of immune thrombocytopenia (ITP) in 2021 correlating with the ongoing vaccination campaign against COVID-19 in a tertiary center - A monocentric analysisC Schaefers, F-O Paulsen, C Frenzel, et al.
Medizinische Klinik (Munich, Germany : 1983)|November 15, 1996
[Risk of secondary neoplasia after treatment of malignant germ cell tumors of the testis]C Bokemeyer, M A Kuczyk, C H Köhne, et al.
Pageof 34